University of Pittsburgh Medical Center (UPMC) led a major clinical trial investigating the outpatient treatment using monoclonal antibodies (mAbs) administered soon after COVID-19. The results…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.